tiprankstipranks
CNS Pharmaceuticals prices $4.0M public offering at 30c per share
PremiumThe FlyCNS Pharmaceuticals prices $4.0M public offering at 30c per share
3M ago
CNS Pharmaceuticals appoints Amy Mahery to board of directors
PremiumThe Fly
CNS Pharmaceuticals appoints Amy Mahery to board of directors
4M ago
CNS Pharmaceuticals completes planned enrollment in study of berubicin in GBM
PremiumThe Fly
CNS Pharmaceuticals completes planned enrollment in study of berubicin in GBM
4M ago
CNS Pharmaceuticals expects cash to fund operations through 4Q23
PremiumThe FlyCNS Pharmaceuticals expects cash to fund operations through 4Q23
6M ago
CNS Pharmaceuticals announces upcoming milestones
PremiumThe Fly
CNS Pharmaceuticals announces upcoming milestones
6M ago
CNS Pharmaceuticals reports Q3 EPS ($1.08) vs. ($2.56) last year
PremiumThe Fly
CNS Pharmaceuticals reports Q3 EPS ($1.08) vs. ($2.56) last year
6M ago
CNS Pharmaceuticals reports Q2 EPS ($1.04) vs. ($2.67) last year
PremiumThe FlyCNS Pharmaceuticals reports Q2 EPS ($1.04) vs. ($2.67) last year
9M ago
CNS Pharmaceuticals provides trial update for ongoing berubicin study
PremiumThe Fly
CNS Pharmaceuticals provides trial update for ongoing berubicin study
9M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100